Isoniazid pharmacokinetics in children treated for respiratory tuberculosis
Open Access
- 1 June 2005
- journal article
- acute paediatrics
- Published by BMJ in Archives of Disease in Childhood
- Vol. 90 (6) , 614-618
- https://doi.org/10.1136/adc.2004.052175
Abstract
Aims: To define the pharmacokinetics of isoniazid (INH) in children with tuberculosis in relation to the N-acetyltransferase 2 (NAT2) genotype. Methods: The first order elimination rate constant (k) and area under the concentration curve (AUC) were calculated in 64 children Results: The mean (SD) k values of the genotypes differed significantly from one another: SS 0.254 (0.046), FS 0.513 (0.074), FF 0.653 (0.117). Within each genotype a median regression of k on age showed a significant decrease in k with age. The mean (SD) INH concentrations (mg/l) two hours after INH administration were SS 8.599 (1.974), FS 5.131 (1.864), and FF 3.938 (1.754). A within genotype regression of 2-hour INH concentrations on age showed a significant increase with age. A within genotype regression of 3-hour, 4-hour, and 5-hour concentrations on age also showed a significant increase with age in each instance. In ethnically similar adults, mean (SD) 2-hour INH concentrations (mg/l) for each genotype were significantly higher than the children’s: SS 10.942 (1.740), FS 8.702 (1.841), and FF 6.031 (1.431). Conclusions: Younger children eliminate INH faster than older children and, as a group, faster than adults, and require a higher mg/kg body weight INH dose to achieve serum concentrations comparable to adults.Keywords
This publication has 25 references indexed in Scilit:
- Isoniazid pharmacokinetics in children according to acetylator phenotypeFundamental & Clinical Pharmacology, 2001
- Role of individual drugs in the chemotherapy of tuberculosis.2000
- Polymerase Chain Reaction with Confronting Two‐pair Primers for Polymorphism GenotypingJapanese Journal of Cancer Research, 2000
- [Changes in the isoniazid inactivation index during antituberculosis treatment in children].1983
- THE PHARMACOKINETICS OF ISONIAZID IN CHILDREN1981
- THERAPEUTIC CONSEQUENCES OF MEASURE OF INACTIVATION INDEX OF ISONIAZID DURING ANTITUBERCULOUS THERAPY1980
- Clinical Pharmacokinetics of IsoniazidClinical Pharmacokinetics, 1979
- MICROBIAL PERSISTENCEThe Journal of Experimental Medicine, 1966
- [Level of active isoniazid in the serum of tuberculous children].1965
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960